Sensitivity of human lymphocytes to genotoxic effect of N-methyl-N-nitrosourea: Possible relation to gynecological cancers

Experimental Oncology

Volumn 28, Issue 4, 2006, Pages 314-318

  Tronov, V A ^a   Kramarenko, I I ^a   Kodova, A D ^a   Dederer, L J ^b   Kedrova, A G ^c   Gorbacheva, L B ^b  

^a SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

^b EMANUEL INSTITUTE OF BIOCHEMICAL PHYSICS   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

DNA double strand breaks; Gynecological cancer; Human lymphocytes; Methylating agents; Mismatch repair (MMR)

Indexed keywords

BROXURIDINE; DOUBLE STRANDED DNA; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; METHYLNITROSOUREA; PHYTOHEMAGGLUTININ;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; FEMALE; GENOTOXICITY; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MISMATCH REPAIR; SENSITIVITY ANALYSIS;

ADULT; AGED; ALKYLATING AGENTS; APOPTOSIS; CELL PROLIFERATION; DNA BREAKS, DOUBLE-STRANDED; DNA MISMATCH REPAIR; DNA, NEOPLASM; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPHOCYTES; METHYLNITROSOUREA; MIDDLE AGED;

EID: 33846854007     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Spitz MR, Hsu TC. Mutagen sensitivity as a marker of cancer risk. Cancer Detection Prevention 1994; 18: 299-304.
2. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000; 92: 874-97.
3. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, Spitz MR. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006; 78: 464-79.
4. Schottenfeld D. Epidemiology of endometrial neoplasia. J Cell Biochem Suppl. 1995; 23: 151-9.
5. Tronov VA, Kramarenko II, Karpukhin AV. Colorectal cancer: mismatch repair eficiency, genomic instability, tolerance to apoptosis, assessment of cancer risk. Vopr Onkol 2005; 52: 159-66.
6. Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for HNPCC (Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453-6.
7. Hickman MJ, Samson LD. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci USA 1999; 96: 10764-69.
8. Kaina B, Ochs K, Grosch S, Fritz G, Lips J, Tomicic M, Dunkern T, Christmann M. BER, MGMT and MMR in defense against alkylation-induced genotoxicity and apoptosis. Progr Nucl Acid Res Mol Biol 2001; 68: 41-54.
9. Tronov VA, Kramarenko II, Smirnova TD, Terekhov SM. Comparision of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines. Cytology (Rus) 2006; 48: 19-27.
10. Tronov V, Konstantinov E, Petrakou E, Tsilimigaki S, Piperakis S. Nicotinamide "protects" resting lymphocytes exposed to hydrogen peroxide from necrosis but not from apoptosis. Cell Biol Toxicol 2002; 18: 359-67.
11. Konca K, Lankoff A, Banasik A, Lisowska H, Kuszewski T, Gozdz S, Koza Z, Wojcik A. A cross-platform public domain PC image-analysis program for the comet assay. Mutat Res 2003; 534: 15-20.
12. Holley WR, Chatterjee A. Clusters of DNA induced by ionizing radiation: formation of short DNA fragments. I. Theoretical modeling. Radiat Res 1996; 145: 188-99.
13. Kaina B, Christmann M. DNA repair in resistance to alkytlating anticancer drugs. Int J Clin Pharm Ther 2002; 40: 354-67.
14. Mayer C, Popanda O, ZeleznyO, von Brevern M-C, Bach A, Bartsch H, Schmezer P. DNA repair capacity after irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes. DNA Repair 2002; 1: 237-50.
15. Tronov VA, Konstantinov EM, Kramarenko II. Role of excision mechanisms of DNA repair in induction of apoptosis. Biochemistry (Moscow) 2002. 67: 730-6.
16. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 1990; 23: 11-30.
17. Kaina B, Fritz G, Conquerelle T. Contribunion of O6-alkylguanine and N-alkylpurines to formation of sister chromatide exchanges, chromosomal aberrations, and gene mutations: new insights ganed from studies of genetically ingineered mammalian cell lines. Envir Mol Mutagen 1993; 22: 283-92.
18. Tatsuka M, Ibeanu GC, Izumi T, Narayan S, Rainana CV, Kim NK, Kang W, Roy G, Mitra S. Structural organization of the mouse DNA repair gene, N-methylpurine-DNA glykosylase. DNA Cell Biol 1995; 14: 37-45.
19. 19. Bignami M, O'Driscoll M, Aquilina G, Karran P. Unmasking a killer: DNA O6-methylguanine and the cytotoxicity of methylating agents. Mutat Res 2000; 462: 71-82.
20. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B, Modrich P. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75: 1227-36.
21. Gifford G, Paul J, Vasey PA, Kaye SB, Brown R. The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients. Clin Cancer Res 2004; 10: 4420-6.
22. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (Remarks). Exp Oncol 2006; 28: 99-105.